A simplified template approach towards the synthesis of a potent beta-3 adrenoceptor agonist at the human receptor

A simplified template approach towards the synthesis of a potent beta-3 adrenoceptor agonist at the human receptor Discovery of a novel, potent and selective human β3-adrenergic receptor agonist Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective β3-adrenergic receptor agonists Stereospecific synthesis and bio-activity of novel β3-adrenoceptor agonists and inverse agonists Synthesis and Human β-Adrenoceptor Activity of 1-(3,5-Diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol Derivatives in Vitro Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β₃-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6 Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β₃-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects Biarylaniline Phenethanolamines as Potent and Selective β₃Adrenergic Receptor Agonists Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β₃Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety